Patients with PD-L1-negative non-small cell lung cancer experienced longer progression-free survival with sac-TMT plus ...

Final KEYNOTE-564 data show Keytruda after kidney cancer surgery lowered the risk of death by 30%. Dr. Toni Choueiri explains ...

A nurse practitioner discusses how an app provides information on cancer treatments, potential side effects and preparing for ...

For National Hospice and Palliative Care Month, answers to common questions about how palliative care differs from hospice, ...

HealthCare.gov open enrollment runs Nov. 1, 2026, to Jan. 15, 2027, and the 2027 out-of-pocket ceiling rises to $12,000. Here ...

A physician emphasized how emotional support, reliable health information and caregiver involvement can encourage men to take ...

For Lung Cancer Awareness Month, answers to common patient questions about biomarker testing in non-small cell lung cancer: ...

After nearly a year of chemotherapy, a patient with stage 4 pancreatic cancer describes daily life and side effects on ...

After a blood cancer diagnosis, a survivor reflects on the close friends who let her be herself and asks whether she is the ...

Dr. Hope S. Rugo explains what KEYNOTE-B49 found about adding Keytruda to chemotherapy for PD-L1-positive, HR-positive, ...

From a new chemotherapy combination to the first RAS-targeted pill, here's what five years of pancreatic cancer approvals mean for patients.

For people with lung or pancreatic cancer driven by changes in the KRAS gene, research presented at the 2026 European Society ...